titanium has been researched along with Sarcoma 180 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Ji, Y; Jiao, X; Zhang, H; Zhang, X; Zhang, Z; Zhu, X | 1 |
| Yuan, HL; Zhao, YW | 1 |
| Keppler, BK; Schmähl, D | 1 |
| Diez, A; Keppler, BK; Seifried, V | 1 |
4 other study(ies) available for titanium and Sarcoma 180
| Article | Year |
|---|---|
A multi-functional nanoplatform for tumor synergistic phototherapy.
Topics: Animals; Drug Compounding; Drug Delivery Systems; Drug Liberation; Female; Hematoporphyrins; Humans; Hyperthermia, Induced; Injections, Subcutaneous; Lasers; MCF-7 Cells; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanocomposites; Nanotubes, Carbon; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Sarcoma 180; Theranostic Nanomedicine; Titanium | 2016 |
[Synthesis and antitumor activity of beta-diketonato complexes of titanium].
Topics: Animals; Antineoplastic Agents; Mice; Organometallic Compounds; Sarcoma 180; Titanium | 1993 |
Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexes.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma 256, Walker; Chemistry, Pharmaceutical; Cisplatin; Columbidae; Drug Evaluation, Preclinical; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Organometallic Compounds; Rats; Sarcoma 180; Titanium | 1986 |
Antitumor activity of phenyl substituted dihalogenobis (1-phenyl-1,3-butanedionato)titanium (IV) compounds.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cisplatin; Lethal Dose 50; Mice; Organometallic Compounds; Sarcoma 180; Titanium | 1985 |